Kyntra Bio, Inc.
USD7.31
+0.07 (+0.97%)
CEO
Thane Wettig
IPO Date
2014-11-14
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$7.25
Prev. Close
$7.24
Day Low
$6.87
Day High
$7.40
52W Low
$4.85
52W High
$12.60
Market Cap
$0.03B
Volume
0.02M
| 7,000 |
| $7.13 |
| 17 Jun 2026 | Kauffman Michael | director | A-Award | Acquired | 7,000 | $7.13 |
| 17 Jun 2026 | Schoeneck James A | director | A-Award | Acquired | 7,000 | $7.13 |
| 9 Jun 2026 | Wettig Thane | director, officer: CEO | F-InKind | Disposed | 198 | $6.71 |
| 9 Jun 2026 | DeLucia David | Chief Financial Officer | F-InKind | Disposed | 52 | $6.71 |
| 19 May 2026 | Wettig Thane | director, officer: CEO | P-Purchase | Acquired | 2,800 | $7.09 |
| 18 May 2026 | Wettig Thane | director, officer: CEO | P-Purchase | Disposed | 2,800 | $7.09 |
| 10 Mar 2026 | Wettig Thane | director, officer: CEO | F-InKind | Disposed | 277 | $6.84 |
| 10 Mar 2026 | DeLucia David | Chief Financial Officer | F-InKind | Disposed | 60 | $6.84 |